Sandoz infringed expired Lexapro patent, judge rules

Corrs Chambers Westgarth 2018-11-29 1:48 pm By Christine Caulfield | Melbourne

Please login to bookmark

Generic drug maker Sandoz has been found liable for patent infringement and misleading and deceptive conduct in a case by pharmaceutical giant Lundbeck over its blockbuster antidepressant Lexapro, ending a battle that has raged for 15 years.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au